A gene for inherited cutaneous venous anomalies ('Glomangiomas') localizes to chromosome 1p21-22

American Journal of Human Genetics

Volumn 65, Issue 1, 1999, Pages 125-133

  Boon, Laurence M ^a,b   Brouillard, Pascal ^a   Irrthum, Alexandre ^a   Karttunen, Leena ^c   Warman, Matthew L ^e   Rudolph, Ross ^f   Mulliken, John B ^d   Olsen, Bjorn R ^c   Vikkula, Miikka ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; THROMBOPLASTIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 1P; CHROMOSOME 9P; CLINICAL ARTICLE; DOMINANT INHERITANCE; ENDOTHELIUM CELL; ENZYME ACTIVATION; FAMILIAL DISEASE; FEMALE; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC RECOMBINATION; GLOMUS TUMOR; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; POSITION EFFECT; PRIORITY JOURNAL;

GLOMUS;

EID: 0033358664     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302450     Document Type: Article

References (32)

1. Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, et al (1997) Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277:1805-1807
2. Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, Warman ML (1994) Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 3:1583-1587
3. Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmback K, Danton MJ, Colbert MC, et al (1996) Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 93:6258-6263
4. Cheung AH, Stewart RJ, Marsden PA (1998) Endothelial Tie2/ Tek ligands angiopoietin-1 (ANGPT1) and angiopoietin-2 (ANGPT2): regional localization of the human genes to 8q22.3-q23 and 8p23. Genomics 48:389-391
5. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, et al (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169
6. Enjolras O, Mulliken JB (1996) Vascular cutaneous anomalies in children: malformations and hemangiomas. Pediatr Surg Int 11:290-295
7. Goodman TF, Abele DC (1971) Multiple glomus tumors: a clinical and electron microscopic study. Arch Dermatol 103: 11-23
8. Gorlin RJ, Fusaro RM, Benton JW (1960) Multiple glomus tumor of the pseudocavernous hemangioma type. Arch Dermatol 82:776-778
9. Huang L, Turck CW, Rao P, Peters KG (1995) GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene 11:2097-2103
10. Iqbal A, Cormack GC, Scerri G (1998) Hereditary multiple glomangiomas. Br J Plast Surg 51:32-37
11. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13:189-195
12. Jones N, Dumont DJ (1998) The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene 17:1097-1108
13. Kontos CD, Stauffer TP, Yang WP, York JD, Huang L, Blanar MA, Meyer T, et al (1998) Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 18: 4131-4140
14. Korpelainen EI, Kärkkäinen M, Gunji Y, Vikkula M, Alitalo K (1999) Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant TIE-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18:1-8
15. Lathrop GM, Lalouel JM, Julier C, Ott J (1984) Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443-3446
16. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand S, Radziejewski C, Compton D, et al (1997) Angiopoietin 2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277(5322): 55-60
17. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345-351
18. Meister A (1974) The gamma-glutamyl cycle: diseases associated with specific enzyme deficiencies. Ann Intern Med 81: 247-253
19. Mulliken JB (1997) Vascular anomalies. In: Aston SJ, Beasly KW, Thorne CHM (eds) Grabb and Smith's plastic surgery, 5th ed. Lippincott-Raven, Philadelphia, pp 191-203
20. Mulliken JB, Young AE (1988) Vascular birthmarks: hemangiomas and malformations. WB Saunders, Philadelphia
21. Rozet JM, Gerber S, Perrault I, Camuzat A, Calvas P, Viegas Pequignot E, Molina Gomes D, et al (1996) Structure and physical mapping of DR1, a TATA-binding protein-associated phosphoprotein gene, to chromosome 1p22.1 and its exclusion in Stargardt disease (STGD). Genomics 36: 554-556
22. Rudolph R (1993) Familial multiple glomangiomas. Ann Plast Surg 30:183-185
23. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, et al (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74
24. Stratmann A, Risau W, Plate KH (1998) Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153:1459-1466
25. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, et al (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180
26. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr (1996) Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88:1583-1587
27. Touraine A, Solente G, Renault P (1936) Tumeurs glomiques multiples du tronc et des membres, Bull Soc Fr Dermatol Syphiligr 43:736-740
28. Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, Zhou H, McClain J, et al (1999) Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 96:1904-1909
29. Vikkula M, Boon LM, Carraway KL III, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, et al (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190
30. Vikkula M, Boon LM, Mulliken JB, Olsen BR (1998) Molecular basis of vascular anomalies. Trends Cardiovasc Med 8: 281-292
31. Vikkula M, Mariman EC, Lui VC, Zhidkova NI, Tiller GE, Goldring MB, van Beersum SE, et al (1995) Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 80:431-437
32. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM (1998) Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273:18514-18521